Effects of solvent on the structure of the Alzheimer amyloid-β(25-35) peptide

被引:140
|
作者
Wei, Guanghong [1 ]
Shea, Joan-Emma [1 ]
机构
[1] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA
基金
美国国家科学基金会;
关键词
D O I
10.1529/biophysj.105.079186
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The free energy landscape for folding of the Alzheimer's amyloid-beta(25-35) peptide is explored using replica exchange molecular dynamics in both pure water and in HFIP/water cosolvent. This amphiphilic peptide is a natural by-product of the Alzheimer's amyloid-beta(1-40) peptide and retains the toxicity of its full-length counterpart as well as the ability to aggregate into beta-sheet-rich fibrils. Our simulations reveal that the peptide preferentially populates a helical structure in apolar organic solvent, while in pure water, the peptide adopts collapsed coil conformations and to a lesser extent beta-hairpin conformations. The beta-hairpin is characterized by a type II' beta-turn involving residues G29 and A30 and two short b-strands involving residues N27, K28, I31, and I32. The hairpin is stabilized by backbone hydrogen- bonding interactions between residues K28 and I31; S26 and G33; and by side-chain-to-side-chain interactions between N27 and I32. Implications regarding the mechanism of aggregation of this peptide into fibrils and the role of the environment in modulating secondary structure are discussed.
引用
收藏
页码:1638 / 1647
页数:10
相关论文
共 50 条
  • [1] Structural diversity of dimers of the Alzheimer amyloid-β(25-35) peptide and polymorphism of the resulting fibrils
    Wei, Guanghong
    Jewett, Andrew I.
    Shea, Joan-Emma
    [J]. PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2010, 12 (14) : 3622 - 3629
  • [2] Prevention of fibrillation of the amyloid-β (25-35) peptide by graphene oxide
    Bag, Sudipta
    DasGupta, Sunando
    Dasgupta, Swagata
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [3] Effect of phospholipid membrane on conformation of retro-sequence amyloid-β-peptide 35-25 and normal amyloid-β-peptide 25-35
    Kodaka, M
    [J]. PROTEIN AND PEPTIDE LETTERS, 2001, 8 (05): : 395 - 398
  • [4] Effects of amyloid-β peptide Aβ25-35 on glycolytic and antioxidant enzymes in erythrocytes of different ages
    Tikhonova, L. A.
    Kaminskii, Yu. G.
    Kosenko, E. A.
    [J]. BIOLOGY BULLETIN, 2014, 41 (04) : 312 - 317
  • [5] Solution structure of amyloid β-peptide (25-35) in different media
    D'Ursi, AM
    Armenante, MR
    Guerrini, R
    Salvadori, S
    Sorrentino, G
    Picone, D
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (17) : 4231 - 4238
  • [6] Structure of the Alzheimer β-amyloid peptide (25-35) and its interaction with negatively charged phospholipid vesicles
    Martínez-Senac, MD
    Villalaín, J
    Gómez-Fernández, JC
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 265 (02): : 744 - 753
  • [7] In vitro degradation of β-amyloid[25-35] peptide
    Jost, K
    Varga, J
    Penke, S
    Zarándi, M
    [J]. PROTEIN AND PEPTIDE LETTERS, 2001, 8 (06): : 423 - 428
  • [8] Subcellular and metabolic examination of amyloid-β peptides in Alzheimer disease pathogenesis: Evidence for Aβ25-35
    Kaminsky, Yury G.
    Marlatt, Michael W.
    Smith, Mark A.
    Kosenko, Elena A.
    [J]. EXPERIMENTAL NEUROLOGY, 2010, 221 (01) : 26 - 37
  • [9] Role of β-Hairpin Formation in Aggregation: The Self-Assembly of the Amyloid-β(25-35) Peptide
    Larini, Luca
    Shea, Joan-Emma
    [J]. BIOPHYSICAL JOURNAL, 2012, 103 (03) : 576 - 586
  • [10] Effect of adrenalectomy on nucleus Meynert neurons in amyloid-β 25-35 peptide-induced model of Alzheimer's disease
    Simonyan, K.
    Mnatsakanyan, V.
    Stepanyan, H.
    Chavushyan, V.
    Meliksetyan, I.
    Avetisyan, Z.
    Mnatsakanyan, H.
    [J]. JOURNAL OF NEUROLOGY, 2010, 257 : S64 - S64